181 related articles for article (PubMed ID: 27048878)
1. Nuclear receptor TLX inhibits TGF-β signaling in glioblastoma.
Johansson E; Zhai Q; Zeng ZJ; Yoshida T; Funa K
Exp Cell Res; 2016 May; 343(2):118-125. PubMed ID: 27048878
[TBL] [Abstract][Full Text] [Related]
2. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
[TBL] [Abstract][Full Text] [Related]
3. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.
Seystahl K; Tritschler I; Szabo E; Tabatabai G; Weller M
Neuro Oncol; 2015 Feb; 17(2):254-65. PubMed ID: 25165192
[TBL] [Abstract][Full Text] [Related]
5. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
6. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
7. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
8. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.
Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS
Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746
[TBL] [Abstract][Full Text] [Related]
9. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.
Silginer M; Burghardt I; Gramatzki D; Bunse L; Leske H; Rushing EJ; Hao N; Platten M; Weller M; Roth P
Oncogene; 2016 Jun; 35(25):3260-71. PubMed ID: 26500056
[TBL] [Abstract][Full Text] [Related]
10. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
[TBL] [Abstract][Full Text] [Related]
11. A tumor-promoting role for soluble TβRIII in glioblastoma.
Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
[TBL] [Abstract][Full Text] [Related]
12. VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation.
Li Y; Cui C; Xie F; Kiełbasa S; Mei H; van Dinther M; van Dam H; Bauer A; Zhang L; Ten Dijke P
J Mol Cell Biol; 2020 Feb; 12(2):138-151. PubMed ID: 31291647
[TBL] [Abstract][Full Text] [Related]
13. HILI inhibits TGF-β signaling by interacting with Hsp90 and promoting TβR degradation.
Zhang K; Lu Y; Yang P; Li C; Sun H; Tao D; Liu Y; Zhang S; Ma Y
PLoS One; 2012; 7(7):e41973. PubMed ID: 22848678
[TBL] [Abstract][Full Text] [Related]
14. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells.
Fukunaga E; Inoue Y; Komiya S; Horiguchi K; Goto K; Saitoh M; Miyazawa K; Koinuma D; Hanyu A; Imamura T
J Biol Chem; 2008 Dec; 283(51):35660-7. PubMed ID: 18927080
[TBL] [Abstract][Full Text] [Related]
15. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
[TBL] [Abstract][Full Text] [Related]
16. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells.
Gramatzki D; Pantazis G; Schittenhelm J; Tabatabai G; Köhle C; Wick W; Schwarz M; Weller M; Tritschler I
Oncogene; 2009 Jul; 28(28):2593-605. PubMed ID: 19465936
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β mimics the key proteome properties of CD133
Bryukhovetskiy I; Shevchenko V; Arnotskaya N; Kushnir T; Pak O; Victor Z; Zaitsev S; Khotimchenko Y; Bryukhovetskiy A; Sharma A; Sharma HS
Int Rev Neurobiol; 2020; 151():219-242. PubMed ID: 32448609
[TBL] [Abstract][Full Text] [Related]
19. HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
Li H; Li J; Chen L; Qi S; Yu S; Weng Z; Hu Z; Zhou Q; Xin Z; Shi L; Ma L; Huang A; Lu Y
Clin Cancer Res; 2019 Jun; 25(12):3602-3616. PubMed ID: 30862693
[TBL] [Abstract][Full Text] [Related]
20. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
